NCT06089668View on ClinicalTrials.gov

An Observational Study to Evaluate Clinical Characteristics of Adult Patients With Suspected or Confirmed Melioidosis

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

October 31, 2024

Study Completion Date

February 2, 2025

Conditions
Melioidosis
Interventions
OTHER

Observational Study

None, this is a non-interventional trial

Trial Locations (3)

34000

Sunpasitthiprasong Hospital, Ubon Ratchathani

40002

Srinagarind Hospital, Khon Kaen

Laos

Mahosot Hospital, Vientiane

Sponsors
All Listed Sponsors
collaborator

Mahidol Oxford Tropical Medicine Research Unit

OTHER

lead

AN2 Therapeutics, Inc

INDUSTRY

NCT06089668 - An Observational Study to Evaluate Clinical Characteristics of Adult Patients With Suspected or Confirmed Melioidosis | Biotech Hunter | Biotech Hunter